Close Menu

    Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    What's Hot

    Japan launches Michibiki No. 7 satellite aboard H3 rocket

    August 12, 2026

    Diesel prices climb amid tight US and European fuel supply

    August 12, 2026

    Denmark July CPI rises 1.3% as annual inflation slows

    August 11, 2026
    Jewish SentinelJewish Sentinel
    • Automotive
    • Business
    • Entertainment
    • Health
    • Lifestyle
    • Luxury
    • News
    • Sports
    • Technology
    • Travel
    Jewish SentinelJewish Sentinel
    Home » NIANCE Unveils Groundbreaking White Paper on Beauty and Longevity: Addressing the 12 Hallmarks of Aging
    PR Newswire

    NIANCE Unveils Groundbreaking White Paper on Beauty and Longevity: Addressing the 12 Hallmarks of Aging

    October 21, 2024
    Facebook Twitter Pinterest LinkedIn Telegram Tumblr Email

    ZURICH, Oct. 21, 2024 /PRNewswire/ — NIANCE, the Swiss luxury skincare and wellness leader, announce the release of its new white paper, “Addressing the 12 Hallmarks of Aging.” This first-of-its-kind document dives into the evolving science of aging and showcases how NIANCE’s innovative products target the biological processes behind aging through advanced biotechnology and active ingredients.

    The ‘Hallmarks of Aging’ framework was first introduced in 2013 by researchers Carlos López-Otín, Maria A. Blasco, Linda Partridge, Manuel Serrano, and Guido Kroemer, who identified nine key biological mechanisms that drive aging, such as genomic instability and mitochondrial dysfunction. In January 2023, Cell published an updated framework that added three new hallmarks: dysbiosis, chronic inflammation, and autophagy dysfunction, increasing the number to 12. NIANCE’s white paper explains these hallmarks and addresses how the brand’s Swiss Glacier Complex®, rich palette of active ingredients and GENR8® supplements target each of the 12 hallmarks specifically to support skin health and overall vitality.

    At the heart of NIANCE’s product development is its proprietary FERNESSE™ biotechnology, which maximizes the bioavailability of over 130 active ingredients used in the formulations. FERNESSE™ ensures that the body fully absorbs these powerful bioactive compounds, enhancing the efficacy of the products and ensuring deep cellular rejuvenation.

    “At NIANCE, we are committed to pioneering products that go beyond addressing surface-level signs of aging,” said Marnix Ettema, CEO of NIANCE. “Our research and innovations, encapsulated in this white paper, demonstrate our mission to help consumers maintain youthful, radiant skin while supporting their overall well-being at a cellular level. We believe this publication will help explain NIANCE’s leadership in translating scientific anti-aging advancements into beauty and longevity solutions that work.”

    The full white paper is available for download on NIANCE’s website, offering in-depth insights into the science behind the brand’s groundbreaking formulations.

    About NIANCE

    NIANCE is a Swiss luxury beauty and longevity brand, renowned for its scientifically advanced formulations developed and the use of FERNESSE™ biotechnology. For over a decade, NIANCE has been exclusively distributed in world-renowned luxury hotel spas, health clinics, and prestigious department stores, including Harrods in London, Kirchhofer in Interlaken and SKP in China. This exclusive access underscores NIANCE’s commitment to offering premium, scientifically advanced products to a discerning global clientele.

    In 2024, world renowned supermodel Natalia Vodianova became a significant shareholder, solidifying her long-standing commitment to the brand.

    Cision View original content:https://www.prnewswire.co.uk/news-releases/niance-unveils-groundbreaking-white-paper-on-beauty-and-longevity-addressing-the-12-hallmarks-of-aging-302281561.html


    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

    Related Posts

    Nitinotes Announces Weill Cornell Medicine and NewYork-Presbyterian/Weill Cornell Medical Center Clinical Site Activation in the EASE™ IDE Trial

    August 11, 2026

    Neurolief Expands Veterans’ Access to Prescription Neuromodulation for Depression and Migraine Through New VA Contract

    August 11, 2026

    WEKA and Andromeda Partner to Power AI Workloads at Global Scale

    July 30, 2026

    Continuity Biosciences Appoints Vicky Papoutsis to Board of Directors

    July 30, 2026

    Nitinotes Announces First Study Procedures at Orlando Health in the EASE™ IDE Trial

    July 28, 2026

    WEKA Debuts NeuralMesh 6 to Power Enterprise and Agentic AI Workloads at Production Scale

    July 21, 2026
    Latest News

    Japan launches Michibiki No. 7 satellite aboard H3 rocket

    August 12, 2026

    TANEGASHIMA, JAPAN / RankWire.AI / – Japan launched its H3 rocket successfully on Tuesday, carrying…

    Diesel prices climb amid tight US and European fuel supply

    August 12, 2026

    Denmark July CPI rises 1.3% as annual inflation slows

    August 11, 2026

    Gold extends three-day rally before US inflation reports

    August 11, 2026

    Extreme heat could cut EU economic growth in 2026

    August 11, 2026

    DR Congo Ebola outbreak passes 1,900 deaths

    August 11, 2026

    Typhoon Dolphin moves inland after mass evacuations in China

    August 11, 2026

    Spain launches border checks for travelers from Italy

    August 10, 2026
    © 2026 Jewish Sentinel | All Rights Reserved
    • Home
    • Contact Us

    Type above and press Enter to search. Press Esc to cancel.